2019
DOI: 10.1016/j.alcohol.2019.02.001
|View full text |Cite
|
Sign up to set email alerts
|

Status of inflammation and alcohol use in a 6-month follow-up study of patients with major depressive disorder

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(11 citation statements)
references
References 36 publications
0
11
0
Order By: Relevance
“…Baseline cortisol levels were not significantly different between hazardous and non-hazardous alcohol users (F ( NAfCo, 2018 ; Archer et al, 2019 ) = 0.464, p = 0.502), although levels did significantly decrease from pre to post sampling F ( NAfCo, 2018 ; Archer et al, 2019 ) = 6.057, p = 0.022; Fig. 1 A).…”
Section: Resultsmentioning
confidence: 90%
See 2 more Smart Citations
“…Baseline cortisol levels were not significantly different between hazardous and non-hazardous alcohol users (F ( NAfCo, 2018 ; Archer et al, 2019 ) = 0.464, p = 0.502), although levels did significantly decrease from pre to post sampling F ( NAfCo, 2018 ; Archer et al, 2019 ) = 6.057, p = 0.022; Fig. 1 A).…”
Section: Resultsmentioning
confidence: 90%
“…Specifically, baseline plasma CRP levels were significantly higher in TT carriers of CRP rs1205 ( Fig. 2 A; F ( NAfCo, 2018 ; Archer et al, 2019 ) = 17.678, p < 0.001, SNK p = 0.001 vs CT and CC), and in GG carriers of FKBP5 rs3800373 ( Fig. 2 B; F (2,24 ) = 5.913, p = 0.009, SNK 0.007 vs TT and 0.016 vs GT).…”
Section: Resultsmentioning
confidence: 92%
See 1 more Smart Citation
“…Previous studies have emphasized the need for novel biomarkers to help detect processes in recovery of depression. All patients in this study were suffering from clinically significant depression, and we have previously reported a decrease in the depressive symptoms in all study groups during the 6 months follow-up [ 30 ]. We have also previously observed elevated serum levels in biomarkers of inflammation in depressed patients, and that the levels of these biomarkers appear to decrease during treatment [ 30 ].…”
Section: Discussionmentioning
confidence: 99%
“…The study was approved by the local ethics committee and all participants provided written informed consent. The study protocol is outlined and published at Ostrobothnia Depression Study in ClinicalTrials.gov , Identifier NCT02520271; first posted date 11/08/2015, and by Archer et al [ 30 ]. The study protocol is described in detail: https://www.clinicaltrials.gov/ct2/show/NCT02520271?term=ODS&draw=2&rank=1 .…”
Section: Methodsmentioning
confidence: 99%